Similarly, overexpression of construct dominant negative WNT2 reduced the tumorigenicity of NSCLC cells in vitro and in vivo via inhibiting FZD8-mediated activation of WNT2/β-catenin pathway [60]. This evidence concerns the gene WNT2 and non-small cell lung carcinoma.